You are here

axial spondyloarthritis

Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis

Fierce Pharma

Mon, 06/1/20 - 11:32 pm

axial spondyloarthritis

Novartis stacks more positive PhIII data on Cosentyx franchise — eyeing approval in non-radiographic axial spondyloarthritis

Endpoints

Wed, 10/2/19 - 10:54 am

axial spondyloarthritis

Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study

TheStreet.com

Mon, 04/22/19 - 10:17 am

axial spondyloarthritis

clinical trials